ACCOUNTS - Final Accounts


Caseware UK (AP4) 2021.0.152 2021.0.152 2021-12-312021-12-31true22021-01-01falseNo description of principal activity3trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09942126 2021-01-01 2021-12-31 09942126 2020-01-01 2020-12-31 09942126 2021-12-31 09942126 2020-12-31 09942126 2020-01-01 09942126 1 2021-01-01 2021-12-31 09942126 1 2020-01-01 2020-12-31 09942126 1 2021-01-01 2021-12-31 09942126 e:Director1 2021-01-01 2021-12-31 09942126 e:RegisteredOffice 2021-01-01 2021-12-31 09942126 d:OfficeEquipment 2021-01-01 2021-12-31 09942126 d:OfficeEquipment 2021-12-31 09942126 d:OfficeEquipment 2020-12-31 09942126 d:CurrentFinancialInstruments 2021-12-31 09942126 d:CurrentFinancialInstruments 2020-12-31 09942126 d:CurrentFinancialInstruments d:WithinOneYear 2021-12-31 09942126 d:CurrentFinancialInstruments d:WithinOneYear 2020-12-31 09942126 d:ShareCapital 2021-12-31 09942126 d:ShareCapital 2020-12-31 09942126 d:ShareCapital 2020-01-01 09942126 d:SharePremium 2021-12-31 09942126 d:SharePremium 1 2021-01-01 2021-12-31 09942126 d:SharePremium 2020-12-31 09942126 d:SharePremium 2020-01-01 09942126 d:SharePremium 1 2020-01-01 2020-12-31 09942126 d:CapitalRedemptionReserve 2021-12-31 09942126 d:CapitalRedemptionReserve 1 2021-01-01 2021-12-31 09942126 d:CapitalRedemptionReserve 2020-12-31 09942126 d:CapitalRedemptionReserve 2020-01-01 09942126 d:RevaluationReserve 1 2020-01-01 2020-12-31 09942126 d:RetainedEarningsAccumulatedLosses 2021-01-01 2021-12-31 09942126 d:RetainedEarningsAccumulatedLosses 2021-12-31 09942126 d:RetainedEarningsAccumulatedLosses 1 2021-01-01 2021-12-31 09942126 d:RetainedEarningsAccumulatedLosses 2020-01-01 2020-12-31 09942126 d:RetainedEarningsAccumulatedLosses 2020-12-31 09942126 d:RetainedEarningsAccumulatedLosses 2020-01-01 09942126 d:RetainedEarningsAccumulatedLosses 1 2020-01-01 2020-12-31 09942126 e:FRS102 2021-01-01 2021-12-31 09942126 e:Audited 2021-01-01 2021-12-31 09942126 e:FullAccounts 2021-01-01 2021-12-31 09942126 e:PrivateLimitedCompanyLtd 2021-01-01 2021-12-31 09942126 e:SmallCompaniesRegimeForAccounts 2021-01-01 2021-12-31 iso4217:GBP xbrli:pure
Registered number: 09942126 (England and Wales)














ABPS R&D LIMITED

DIRECTOR'S REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2021


 
ABPS R&D LIMITED
 

 
COMPANY INFORMATION


Director
B Watson 




Registered number
09942126



Registered office
New Penderel House
4th Floor

283-288 High Holborn

London

England

WC1V 7HP




Independent auditors
ZEDRA Corporate Reporting Services (UK) Limited






 
ABPS R&D LIMITED
 


CONTENTS



Page
Balance Sheet
 
1 - 2
Statement of Changes in Equity
 
3
Notes to the Financial Statements
 
4 - 8



 
ABPS R&D LIMITED
REGISTERED NUMBER:09942126


BALANCE SHEET
AS AT 31 DECEMBER 2021

2021
2020
Note
£
£

  

Tangible fixed assets
 4 
-
-

  
-
-

Current assets
  

Debtors: amounts falling due within one year
 5 
175,688
8,115

Bank and cash balances
  
27,568
27,895

  
203,256
36,010

Creditors: amounts falling due within one year
 6 
(36,660)
(60,193)

Net current assets/(liabilities)
  
 
 
166,596
 
 
(24,183)

Total assets less current liabilities
  
166,596
(24,183)

  

Net assets/(liabilities)
  
166,596
(24,183)

Page 1


 
ABPS R&D LIMITED
REGISTERED NUMBER:09942126

    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2021

2021
2020
Note
£
£

Capital and reserves
  

Called up share capital 
  
100
100

Share premium account
 
102,580
102,580

Capital contribution reserve
 7 
952,709
771,340

Profit and loss account

(888,793)
(898,203)

  
166,596
(24,183)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 September 2022.




................................................
B Watson
Director

The notes on pages 4 to 8 form part of these financial statements.

Page 2


 
ABPS R&D LIMITED
 


STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2021


Called up share capital
Share premium account
Capital contribution reserve
Profit and loss account
Total equity

£
£
£
£
£


At 1 January 2020
100
102,580
696,340
(801,933)
(2,913)


Comprehensive income for the year

Loss for the year

-
-
-
(96,270)
(96,270)

Capital contribution (note 7)
-
-
75,000
-
75,000



At 1 January 2021
100
102,580
771,340
(898,203)
(24,183)


Comprehensive income for the year

Profit for the year

-
-
-
9,410
9,410

Capital contribution (note 7)
-
-
181,369
-
181,369


At 31 December 2021
100
102,580
952,709
(888,793)
166,596


Page 3


 
ABPS R&D LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

  
1.2

Going concern

ABPS R&D Limited is in a net asset position of £166,596, but despite this is reliant on the support of the ultimate parent company. The company has received written confirmation from its ultimate parent company, Wincrest Ventures, L.P., that it will continue to provide financial support to the Company for a period of at least 12 months from the date of signing these financial statements. For this reason, the director continues to adopt the going concern basis in preparing the financial statements.
The following principal accounting policies have been applied:

 
1.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
1.4

Turnover

Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Rendering of services

Turnover from intercompany and external consulting and services agreements is recognised in the year when the following conditions are satisfied:
 
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the agreement; and
the costs incurred and the costs to complete the services outlined in the agreement can be measured reliably.

Page 4


 
ABPS R&D LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

1.Accounting policies (continued)

 
1.5

Research and development costs

Research and development costs are expensed in the period that they are incurred.

 
1.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
1.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
3 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Comprehensive Income.

 
1.8

Debtors

Short term debtors are measured at transaction price, less any impairment. Amounts owed by group undertakings are intercompany loans measured at cost. These loans are unsecured, interest free and repayable on demand.

 
1.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions.

 
1.10

Creditors

Short term creditors are measured at the transaction price. 

Page 5


 
ABPS R&D LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

1.Accounting policies (continued)

  
1.11

Share premium

Share premium account represents the excess of the issue price over the par value on shares issued less transaction costs arising on issue.

  
1.12

Other operating income

Other operating income represents costs borne by the UK recharged to the parent company. 
Other operating income also includes grant income receivable. The Company recognises grant income using the performance model, recognising the income receivable in the period in which services are provided.


2.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2021 was unqualified.

The audit report was signed on 30 September 2022 by Nick Whitehead FCCA (Senior Statutory Auditor) on behalf of ZEDRA Corporate Reporting Services (UK) Limited.


3.


Employees

The average monthly number of employees during the year was 3 (2020 - 2).

Page 6


 
ABPS R&D LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 January 2021
1,977



At 31 December 2021

1,977



Depreciation


At 1 January 2021
1,977



At 31 December 2021

1,977



Net book value



At 31 December 2021
-



At 31 December 2020
-

Page 7


 
ABPS R&D LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021

5.


Debtors

2021
2020
£
£


Trade debtors
-
8,115

Amounts owed by group undertakings
52,386
-

Other debtors
4,443
-

Tax recoverable
118,859
-

175,688
8,115



6.


Creditors: Amounts falling due within one year

2021
2020
£
£

Trade creditors
10,860
336

Other taxation and social security
6,722
8,990

Other creditors
1,107
1,367

Accruals and deferred income
17,971
49,500

36,660
60,193



7.


Capital contribution reserve

During the year, the parent company, Advanced Blast Protection Systems, LLC made a capital contribution totalling £181,369 (2020: £75,000) to the Company. There is no intention for this amount to be repaid and has therefore been considered as a capital contribution.


8.


Controlling party

Advanced Blast Protection Systems, LLC is the parent company of the smallest group for which consolidated financial statements are drawn up of which the Company is a member. The registered office of the parent company is 4265 San Felipe, Suite 800, Houston, TX 77027, United States of America.


9.


Post balance sheet events

There were no adjusting or non-adjusting post balance sheet events occurring between the end of the reporting period and the date these financial statements were approved.

 
Page 8